St. Jude Medical Announces Leadership Transition Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
St. Jude Medical (STJ) Chairman, CEO Starks to Retire; Successor Named
September 9, 2015 10:25 AM EDTSt. Jude Medical (NYSE: STJ) announced that its Board of Directors has implemented a leadership transition plan that capitalizes on the strength of the St. Jude Medical management team. Effective January 1, 2016, Michael T. Rousseau will become President and Chief Executive Officer (CEO) and a member of the St. Jude Medical Board of Directors. Daniel J. Starks, following a distinguished career as St. Jude Medicals Chairman, President and Chief Executive Officer, has decided to retire from his position as President and Chief Executive Officer and has been elected Executive Chairman of the St. Jude... More
